Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition

Abstract

Pituitary tumor transforming gene (PTTG1) was isolated from rat pituitary tumor cells, and subsequently identified as a securin protein as well as a transcription factor. We show here a global transcriptional effect of PTTG1 in human choriocarcinoma JEG-3 cells by simultaneously assessing 20 000 gene promoters using chromatin immunoprecipitation (ChIP)-on-Chip experiments. Seven hundred and forty-six gene promoters (P<0.001) were found enriched, with functions relating to cell cycle, metabolic control and signal transduction. Significant interaction between PTTG1 and Sp1 (P<0.000001) was found by transcriptional pattern analysis of ChIP data and further confirmed by immunoprecipitation and pull-down assays. PTTG1 acts coordinately with Sp1 to induce cyclin D3 expression threefold, and promotes G1/S-phase transition independently of p21. PTTG1 deletion was also protective for anchorage-independent cell colony formation. The results show that PTTG1 exhibits properties of a global transcription factor, and specifically modulates the G1/S-phase transition by interacting with Sp1. This novel signaling pathway may be required for PTTG1 transforming activity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Abbreviations

ChIP:

chromatin immunoprecipitation

MEF:

mouse embryo fibroblast

PTTG:

pituitary tumor transforming gene

References

  • Abdelrahim M, Samudio I, Smith III R, Burghardt R, Safe S . (2002). Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells. J Biol Chem 277: 28815–28822.

    Article  CAS  Google Scholar 

  • Bernal JA, Luna R, Espina A, Lazaro I, Ramos-Morales F, Romero F et al. (2002). Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat Genet 32: 306–311.

    Article  CAS  Google Scholar 

  • Boelaert K, Tannahill LA, Bulmer JN, Kachilele S, Chan SY, Kim D et al. (2003). A potential role for PTTG/securin in the developing human fetal brain. FASEB J 17: 1631–1639.

    Article  CAS  Google Scholar 

  • Chesnokova V, Kovacs K, Castro AV, Zonis S, Melmed S . (2005). Pituitary hypoplasia in Pttg−/− mice is protective for Rb+/− pituitary tumorigenesis. Mol Endocrinol 19: 2371–2379.

    Article  CAS  Google Scholar 

  • Chien W, Pei L . (2000). A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product. J Biol Chem 275: 19422–19427.

    Article  CAS  Google Scholar 

  • Clem AL, Hamid T, Kakar SS . (2003). Characterization of the role of Sp1 and NF-Y in differential regulation of PTTG/securin expression in tumor cells. Gene 322: 113–121.

    Article  CAS  Google Scholar 

  • Dominguez A, Ramos-Morales F, Romero F, Rios RM, Dreyfus F, Tortolero M et al. (1998). hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG. Oncogene 17: 2187–2193.

    Article  CAS  Google Scholar 

  • Grinstein E, Jundt F, Weinert I, Wernet P, Royer HD . (2002). Sp1 as G1 cell cycle phase specific transcription factor in epithelial cells. Oncogene 21: 1485–1492.

    Article  CAS  Google Scholar 

  • Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S . (1999). Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 5: 1317–1321.

    Article  CAS  Google Scholar 

  • Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashima M, Melmed S . (2000). Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 355: 716–719.

    Article  CAS  Google Scholar 

  • Honda S, Hayashi M, Kobayashi Y, Ishikawa Y, Nakagawa K, Tsuchiya E . (2003). A role for the pituitary tumor-transforming gene in the genesis and progression of non-small cell lung carcinomas. Anticancer Res 23: 3775–3782.

    CAS  PubMed  Google Scholar 

  • Khan S, Abdelrahim M, Samudio I, Safe S . (2003). Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells. Endocrinology 144: 2325–2335.

    Article  CAS  Google Scholar 

  • Li Z, Van CS, Qu C, Cavenee WK, Zhang MQ, Ren B . (2003). A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci USA 100: 8164–8169.

    Article  CAS  Google Scholar 

  • McCabe CJ, Khaira JS, Boelaert K, Heaney AP, Tannahill LA, Hussain S et al. (2003). Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour. Clin Endocrinol (Oxford) 58: 141–150.

    Article  CAS  Google Scholar 

  • Pei L . (2000). Activation of mitogen-activated protein kinase cascade regulates pituitary tumor-transforming gene transactivation function. J Biol Chem 275: 31191–31198.

    Article  CAS  Google Scholar 

  • Pei L . (2001). Identification of c-myc as a down-stream target for pituitary tumor-transforming gene. J Biol Chem 276: 8484–8491.

    Article  CAS  Google Scholar 

  • Pei L, Melmed S . (1997). Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 11: 433–441.

    Article  CAS  Google Scholar 

  • Ren B, Robert F, Wyrick JJ, Aparicio O, Jennings EG, Simon I et al. (2000). Genome-wide location and function of DNA binding proteins. Science 290: 2306–2309.

    Article  CAS  Google Scholar 

  • Ryuto M, Ono M, Izumi H, Yoshida S, Weich HA, Kohno K et al. (1996). Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem, 271. 28220–28228.

  • Saez C, Japon MA, Ramos-Morales F, Romero F, Segura DI, Tortolero M et al. (1999). hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene 18: 5473–5476.

    Article  CAS  Google Scholar 

  • Safe S, Abdelrahim M . (2005). Sp transcription factor family and its role in cancer. Eur J Cancer 41: 2438–2448.

    Article  CAS  Google Scholar 

  • Solbach C, Roller M, Fellbaum C, Nicoletti M, Kaufmann M . (2004). PTTG mRNA expression in primary breast cancer: a prognostic marker for lymph node invasion and tumor recurrence. Breast 13: 80–81.

    Article  Google Scholar 

  • Tarabykin V, Britanova O, Fradkov A, Voss A, Katz LS, Lukyanov S et al. (2000). Expression of PTTG and prc1 genes during telencephalic neurogenesis. Mech Dev 92: 301–304.

    Article  CAS  Google Scholar 

  • Wang Z, Melmed S . (2000). Pituitary tumor transforming gene (PTTG) transforming and transactivation activity. J Biol Chem 275: 7459–7461.

    Article  CAS  Google Scholar 

  • Wang Z, Moro E, Kovacs K, Yu R, Melmed S . (2003). Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes. Proc Natl Acad Sci USA 100: 3428–3432.

    Article  CAS  Google Scholar 

  • Wang Z, Yu R, Melmed S . (2001). Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Mol Endocrinol 15: 1870–1879.

    Article  CAS  Google Scholar 

  • Wang Z, Zhang Y, Lu J, Sun S, Ravid K . (1999). Mpl ligand enhances the transcription of the cyclin D3 gene: a potential role for Sp1 transcription factor. Blood 93: 4208–4221.

    CAS  PubMed  Google Scholar 

  • Yu R, Ren SG, Horwitz GA, Wang Z, Melmed S . (2000). Pituitary tumor transforming gene (PTTG) regulates placental JEG-3 cell division and survival: evidence from live cell imaging. Mol Endocrinol 14: 1137–1146.

    Article  CAS  Google Scholar 

  • Zou H, McGarry TJ, Bernal T, Kirschner MW . (1999). Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285: 418–422.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

p21−/− HCT116 cells were kindly provided by Dr Bert Vogelstein, Johns Hopkins University. Mouse embryos were kindly provided by Vera Chesnokova. Retroviral plasmids pBabe-ras, pWZL-E1A, pWZL-Myc and pWZL-T-Ag were from Dr Pandolfi, Memorial Sloan-Kettering Cancer Center. This work was supported by NIH Grant CA 75979 (SM) and The Doris Factor Molecular Endocrinology Laboratory.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Melmed.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tong, Y., Tan, Y., Zhou, C. et al. Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition. Oncogene 26, 5596–5605 (2007). https://doi.org/10.1038/sj.onc.1210339

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210339

Keywords

Search

Quick links